REBER GENETICS CO LTD |
End-of-day quote
Other stock markets
|
||
| - | - |
|
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Managers | Title | Age | Since |
|---|---|---|---|
Sunny Chiang
CEO | Chief Executive Officer | - | 17/19/17 |
Kuo Yan Chen
DFI | Director of Finance/CFO | - | - |
Frank Chang
CTO | Chief Tech/Sci/R&D Officer | - | 01/19/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hsiu Chi Chang
BRD | Director/Board Member | - | 28/11/28 |
Chi Jung Ho
BRD | Director/Board Member | - | 17/19/17 |
Cheng Chen
BRD | Director/Board Member | 69 | 25/14/25 |
Reber Genetics Co., Ltd. is a Taiwan-based company principally engaged in the research, development, production and sales of animal vaccines. The Company's main products include PRRSFREETM, a genetically modified subunit vaccine for reproductive and respiratory syndrome in wide pigs; CIRCOFREE, a genetically modified subunit vaccine for porcine circovirus (PCV) infection, and PCCOM, a genetically modified subunit mixed vaccine for PCV infection and reproductive and respiratory syndrome in Shuangbao pigs. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -2.61% | 89.08B | |
| +3.55% | 40.9B | |
| -14.40% | 32.25B | |
| +55.89% | 25.14B | |
| -15.96% | 15.39B | |
| -15.50% | 11.91B | |
| -41.29% | 11.89B | |
| -11.75% | 11.64B | |
| +7.87% | 9.03B |
- Stock Market
- Equities
- Stock